by Ian Ingram
Source: Medpagetoday
Screening for hepatocellular carcinoma (HCC) in liver disease patients with cirrhosis may indeed lead to a survival benefit, a retrospective analysis of data from two large U.S. health systems suggested.
Among more than 1,300 patients diagnosed with HCC, the median survival reached 37 months for those with screening-detected tumors compared with 19 months for those whose tumors were found incidentally or due to symptoms (unadjusted HR 0.65, 95% CI 0.56-0.75).
Read more https://www.medpagetoday.com/gastroenterology/generalhepatology/109919